FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

9543711000001108: Agalsidase alfa 3.5mg/3.5ml solution for injection vials 4 vial (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
31111501000001114 Agalsidase alfa 3.5mg/3.5ml solution for injection vials 4 vial (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
52516401000001115 Agalsidase alfa 3.5mg/3.5ml solution for infusion vials 4 vial en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Agalsidase alfa 3.5mg/3.5ml solution for injection vials 4 vial Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Agalsidase alfa 3.5mg/3.5ml solution for injection vials 4 vial Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Agalsidase alfa 3.5mg/3.5ml solution for injection vials 4 vial Is pack of Agalsidase alfa 3.5mg/3.5ml solution for injection vials false Inferred relationship Existential restriction modifier
Agalsidase alfa 3.5mg/3.5ml solution for injection vials 4 vial Has active ingredient Alpha-galactosidase false Inferred relationship Existential restriction modifier
Agalsidase alfa 3.5mg/3.5ml solution for injection vials 4 vial VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Agalsidase alfa 3.5mg/3.5ml solution for injection vials 4 vial VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Agalsidase alfa 3.5mg/3.5ml solution for injection vials 4 vial Has manufactured dose form Conventional release solution for injection false Inferred relationship Existential restriction modifier
Agalsidase alfa 3.5mg/3.5ml solution for injection vials 4 vial Has VMP Agalsidase alfa 3.5mg/3.5ml solution for injection vials true Inferred relationship Existential restriction modifier
Agalsidase alfa 3.5mg/3.5ml solution for injection vials 4 vial Has specific active ingredient Agalsidase alfa false Inferred relationship Existential restriction modifier
Agalsidase alfa 3.5mg/3.5ml solution for injection vials 4 vial Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Agalsidase alfa 3.5mg/3.5ml solution for injection vials 4 vial Has specific active ingredient Agalsidase alfa true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Replagal 3.5mg/3.5ml solution for infusion vials (Takeda UK Ltd) 4 vial Is a True Agalsidase alfa 3.5mg/3.5ml solution for injection vials 4 vial Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start